ATE458485T1 - Ubiquitin-ligase-hemmer und verwandte verfahren - Google Patents

Ubiquitin-ligase-hemmer und verwandte verfahren

Info

Publication number
ATE458485T1
ATE458485T1 AT04777768T AT04777768T ATE458485T1 AT E458485 T1 ATE458485 T1 AT E458485T1 AT 04777768 T AT04777768 T AT 04777768T AT 04777768 T AT04777768 T AT 04777768T AT E458485 T1 ATE458485 T1 AT E458485T1
Authority
AT
Austria
Prior art keywords
ubiquitin ligase
related methods
compounds
ligase inhibitors
inhibitors
Prior art date
Application number
AT04777768T
Other languages
English (en)
Inventor
Iris Alroy
Shmuel Tuvia
Yuval Reiss
Ofra Levi-Hacham
Original Assignee
Proteologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/035712 external-priority patent/WO2004098492A2/en
Priority claimed from PCT/US2004/006308 external-priority patent/WO2004078130A2/en
Priority claimed from PCT/US2004/006619 external-priority patent/WO2004099388A2/en
Priority claimed from PCT/US2004/010582 external-priority patent/WO2004089302A2/en
Priority claimed from PCT/US2004/016865 external-priority patent/WO2005001485A2/en
Application filed by Proteologics Inc filed Critical Proteologics Inc
Application granted granted Critical
Publication of ATE458485T1 publication Critical patent/ATE458485T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
AT04777768T 2003-07-11 2004-07-09 Ubiquitin-ligase-hemmer und verwandte verfahren ATE458485T1 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US48673003P 2003-07-11 2003-07-11
US48979503P 2003-07-24 2003-07-24
PCT/US2003/035712 WO2004098492A2 (en) 2002-11-11 2003-11-10 Trans-golgi network-associated processes, methods and compositions related thereto
US54989604P 2004-03-02 2004-03-02
PCT/US2004/006308 WO2004078130A2 (en) 2003-03-03 2004-03-02 Posh interacting proteins and related methods
PCT/US2004/006619 WO2004099388A2 (en) 2003-03-05 2004-03-05 Cbl-b polypeptides, complexes and related methods
PCT/US2004/010582 WO2004089302A2 (en) 2003-04-03 2004-04-05 Posh polypeptides, complexes and related methods
PCT/US2004/016865 WO2005001485A2 (en) 2003-05-30 2004-05-28 Pem-3-like compositions and related methods thereof
PCT/US2004/021900 WO2005007141A2 (en) 2003-07-11 2004-07-09 Ubiquitin ligase inhibitors and methods related thereto

Publications (1)

Publication Number Publication Date
ATE458485T1 true ATE458485T1 (de) 2010-03-15

Family

ID=41795377

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04777768T ATE458485T1 (de) 2003-07-11 2004-07-09 Ubiquitin-ligase-hemmer und verwandte verfahren

Country Status (5)

Country Link
US (1) US7659277B2 (de)
EP (1) EP1651226B1 (de)
AT (1) ATE458485T1 (de)
DE (1) DE602004025708D1 (de)
WO (1) WO2005007141A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526780A1 (en) * 2003-05-30 2005-01-06 Proteologics, Inc. Pem-3-like compositions and related methods thereof
JP2007522204A (ja) * 2004-02-11 2007-08-09 ペインセプター ファーマ コーポレーション ニューロトロフィンが媒介する活性を調節する方法
FI20041129A0 (fi) * 2004-08-30 2004-08-30 Ctt Cancer Targeting Tech Oy Tioksotiatsolidinoniyhdisteitä lääkkeinä käytettäviksi
WO2006047162A2 (en) * 2004-10-21 2006-05-04 The Burnham Institute Compositions and methods for treatment of disease caused by yersinia spp infection
US20090263821A1 (en) * 2004-12-01 2009-10-22 Proteologics, Inc. Ubiquitin Ligase Assays And Related Reagents
ITMI20042475A1 (it) * 2004-12-23 2005-03-23 Cell Therapeutics Europe Srl Uso di derivati tiazolidinonici come agenti terapeutici
US8257931B2 (en) 2005-01-21 2012-09-04 President And Fellows Of Harvard College Regulation of protein synthesis
CA2608821A1 (en) * 2005-06-15 2006-12-28 Shibo Jiang Anti-viral compositions comprising heterocyclic substituted phenyl furans and related compounds
WO2007088531A2 (en) * 2006-02-02 2007-08-09 Proteologics Ltd. Pem-3-like polypeptides, complexes, and related methods
DE102006008321A1 (de) * 2006-02-17 2007-08-30 Virologik Gmbh Mittel zur Behandlung von Infektionen mit Influenzaviren
CA2667839C (en) * 2006-10-30 2016-01-12 Hybrigenics Sa Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
MX2009005478A (es) * 2006-11-27 2009-08-12 Lundbeck & Co As H Derivados de heteroarilamida.
WO2008094319A2 (en) * 2007-02-01 2008-08-07 The Board Of Regents Of The University Of Texas Sytem Methods and compositions of trail-death receptor agonists/activators
US20080221056A1 (en) * 2007-02-12 2008-09-11 Johns Hopkins University Early Detection and Prognosis of Colon Cancers
WO2008099022A1 (en) * 2007-02-16 2008-08-21 Tibotec Pharmaceuticals Ltd. 10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors
WO2009024980A2 (en) * 2007-08-22 2009-02-26 Proteologics Ltd Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors
DE102007040336A1 (de) * 2007-08-27 2009-03-05 Johann Wolfgang Goethe-Universität Frankfurt am Main Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen
AT506041A1 (de) * 2007-12-10 2009-05-15 Univ Innsbruck Verfahren zur erhöhung der immunreaktivität
US9018238B2 (en) * 2009-02-12 2015-04-28 Pharmadesign, Inc. Inhibitor of casein kinase 1δ and casein kinase 1ε
JP2013512234A (ja) * 2009-11-30 2013-04-11 プロテオロジクス リミテッド 小型ピリミジン誘導体およびその使用の方法
EP2555764A1 (de) * 2010-04-09 2013-02-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Antimikrobielle verbindungen von 1,4-naphtochinonstruktur
US9073941B2 (en) 2010-06-28 2015-07-07 Academia Sinica Compounds and methods for treating tuberculosis infection
JP6208122B2 (ja) * 2011-05-12 2017-10-04 プロテオステイシス セラピューティクス，インコーポレイテッド プロテオスタシス調節因子
WO2014179785A1 (en) * 2013-05-03 2014-11-06 Inscent, Inc. Improved honeybee repellents and uses thereof
AR110456A1 (es) * 2016-01-13 2019-04-03 Bayer Cropscience Ag Uso de sustancias activas para controlar infecciones por virus en plantas
EP3577109A4 (de) * 2017-01-31 2020-11-18 Arvinas Operations, Inc. Cereblonliganden und bifunktionale verbindungen damit
JP2023507570A (ja) 2019-12-19 2023-02-24 アルビナス・オペレーションズ・インコーポレイテッド アンドロゲン受容体の標的分解のための化合物および方法
CN114592006A (zh) * 2022-04-29 2022-06-07 昆明理工大学 Memo1基因的新用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE590586A (de) * 1959-05-07
JPS6253963A (ja) * 1985-08-31 1987-03-09 Taisho Pharmaceut Co Ltd 肝疾患治療剤
IL141456A0 (en) * 1998-08-21 2002-03-10 Viropharma Inc Rhodanine derivatives and pharmaceutical compositions containing the same
CN1288667A (zh) * 1999-09-21 2001-03-28 马越 乙霉威·多菌灵杀菌组合物
US20040009613A1 (en) * 2001-02-16 2004-01-15 Ming-Ming Zhou Methods of identifying modulators of bromodomains
WO2001077091A2 (en) * 2000-04-05 2001-10-18 Tularik Inc. Ns5b hcv polymerase inhibitors
AU2001240021A1 (en) * 2000-04-13 2001-10-30 Millennium Pharmaceuticals, Inc. Diazafluorenone il-8 receptor antagonists
GB0013655D0 (en) * 2000-06-05 2000-07-26 Prolifix Ltd Therapeutic compounds
WO2002062337A1 (en) * 2000-12-18 2002-08-15 Smithkline Beecham Corporation Thiazolidinediones
AU2002218897A1 (en) * 2000-12-18 2002-07-01 Boehringer Ingelheim (Canada) Ltd. Inhibitors of papilloma virus
GB2376943B (en) * 2001-05-18 2005-03-16 Pantherix Ltd Compounds and their therapeutic use
EP1310552B1 (de) 2001-11-09 2007-06-13 Proteologics, Inc. Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
WO2004098492A2 (en) * 2002-11-11 2004-11-18 Proteologics, Inc. Trans-golgi network-associated processes, methods and compositions related thereto
FR2833949B1 (fr) * 2001-12-21 2005-08-05 Galderma Res & Dev NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
WO2003074497A1 (en) * 2002-03-01 2003-09-12 Pintex Pharmaceutical, Inc. Pin1-modulating compounds and methods of use thereof
EP1556059A4 (de) * 2002-06-06 2010-06-30 Smithkline Beecham Thrombopoietin-mimetika
MXPA05000453A (es) * 2002-07-10 2005-03-23 Applied Research Systems Derivados de benceno fusionados a azolidinona-vinilo.
EP1389461A1 (de) * 2002-08-14 2004-02-18 Axxima Pharmaceuticals Aktiengesellschaft Pyrimidone mit antiviralen Eigenschaften
AU2004218430A1 (en) * 2003-03-03 2004-09-16 Proteologics, Inc. Posh interacting proteins and related methods
WO2004089302A2 (en) * 2003-04-03 2004-10-21 Proteologics, Inc. Posh polypeptides, complexes and related methods

Also Published As

Publication number Publication date
EP1651226A2 (de) 2006-05-03
WO2005007141A2 (en) 2005-01-27
EP1651226B1 (de) 2010-02-24
US7659277B2 (en) 2010-02-09
WO2005007141A3 (en) 2005-03-24
DE602004025708D1 (de) 2010-04-08
US20070015768A1 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
ATE458485T1 (de) Ubiquitin-ligase-hemmer und verwandte verfahren
WO2006028958A3 (en) Pyridyl inhibitors of hedgehog signalling
MX2007004276A (es) 1,5-naftiridin-azolidinonas que tienen actividad antiproliferativa de cdk-1.
CY1116754T1 (el) Παραγωγα νιτροκατεχολης ως αναστολεις της comt
ATE523196T1 (de) Mitotische kinesinhemmer und verfahren zu ihrer verwendung
GEP20084420B (en) Use of imidazole compounds for the treatment of neurodegenerative disorders
TW200700422A (en) Compounds for inhibiting ksp kinesin activity
TW200510416A (en) P38 inhibitors and methods of use thereof
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
ATE424388T1 (de) Mitotische kinesinhemmer
ATE447577T1 (de) Mitotische kinesin-hemmer
EA200970447A1 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
ATE437861T1 (de) 2-(amino-substituierte)-4-arylpyramidine und verwandte verbindungen, die sich für die behandlung von entzündlichen krankheiten eignen
TW200700066A (en) Compounds for inhibiting ksp kinesin activity
WO2004058148A3 (en) Mitotic kinesin inhibitors
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2004058700A3 (en) Mitotic kinesin inhibitors
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
BRPI0615141A2 (pt) inibidores pentacìclicos de quinase
TW200716153A (en) Mitotic kinesin inhibitors and methods of use thereof
IS7970A (is) PDE4-hemlar til að meðhöndla eitlafrumuæxli
WO2002060375A3 (en) Diphenyl ether derivatives and their uses as heparanase inhibitors
DE60329326D1 (de) Tace inhibitoren
WO2004060878A3 (en) Inhibitors of phosphatases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties